Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
SK

Scott D. Kuduk

Merck: 83 patents #33 of 9,382Top 1%
NTNovira Therapeutics: 20 patents #2 of 13Top 20%
SRSloan Kettering Institute For Cancer Research: 8 patents #43 of 644Top 7%
Johnson & Johnson: 6 patents #1,608 of 7,810Top 25%
YUYuhan: 4 patents #47 of 274Top 20%
Spring House, PA: #2 of 102 inventorsTop 2%
Pennsylvania: #114 of 74,527 inventorsTop 1%
Overall (All Time): #10,280 of 4,157,543Top 1%
118 Patents All Time

Issued Patents All Time

Showing 51–75 of 118 patents

Patent #TitleCo-InventorsDate
9556190 Piperidinyloxy lactone orexin receptor antagonists Jason W. Skudlarek 2017-01-31
9556145 2-pyridyloxy-4-ester orexin receptor antagonists Jason W. Skudlarek 2017-01-31
9550786 4-fluoropiperidine orexin receptor antagonists Andrew Cooke, Craig A. Stump, Peter D. Williams 2017-01-24
9550779 Derivatives and methods of treating hepatitis B infections George D. Hartman 2017-01-24
9546152 2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists Jason W. Skudlarek 2017-01-17
9527845 Derivatives and methods of treating hepatitis B infections George D. Hartman 2016-12-27
9518057 Derivatives and methods of treating hepatitis B infections George D. Hartman 2016-12-13
9505722 Azepane derivatives and methods of treating hepatitis B infections George D. Hartman 2016-11-29
9428492 Secondary alcohol substituted triazoles as PDE10 inhibitors Christopher D. Cox, Vadim Dudkin, Carol A. McVean, Thomas S. Reger, Justin T. Steen 2016-08-30
9365562 1,3 substituted azetidine PDE10 inhibitors Christopher D. Cox, Douglas C. Beshore, June J. Kim, Carol A. McVean, Thomas S. Reger +1 more 2016-06-14
9359348 Cyclopropyl imidazopyridine PDE10 inhibitors Douglas C. Beshore, Thomas S. Reger 2016-06-07
9353104 Substituted pyridizinone derivatives as PDE10 inhibitors Casey Cameron McComas, Thomas S. Reger, Changhe Qi 2016-05-31
9339510 Azepane derivatives and methods of treating hepatitis B infections George D. Hartman 2016-05-17
9284312 N-methyl tetrahydroquinoline M1 receptor positive allosteric modulators Christina Ng DiMarco, Thomas J. Greshock 2016-03-15
9284302 Cyclobutyl benzimidazoles as PDE 10 inhibitors Casey Cameron McComas, Thomas S. Reger 2016-03-15
9273033 Substituted pyridone derivatives as PDE10 inhibitors Casey Cameron McComas, Thomas S. Reger 2016-03-01
9260418 Pyranyl aryl methyl benzoquinolinone M1 receptor positive allosteric modulators Ronald K. Chang, Thomas J. Greshock 2016-02-16
9206200 N-linked lactam M1 receptor positive allosteric mogulators Douglas C. Beshore, Zhi-Qiang Yang, Youheng Shu, Daniel L. Pitts 2015-12-08
9200001 Triazolyl PDE10 inhibitors Christopher D. Cox, Vadim Dudkin, June J. Kim, Carol A. McVean, Thomas S. Reger +2 more 2015-12-01
9199939 Quinoline amide M1 receptor positive allosteric modulators Kelly-Ann S. Schlegel, Zhi-Qiang Yang 2015-12-01
9181288 Azepane derivatives and methods of treating hepatitis B infections George D. Hartman 2015-11-10
9169212 Azepane derivatives and methods of treating hepatitis B infections George D. Hartman 2015-10-27
9156819 2-pyridyloxy-4-nitrile orexin receptor antagonists Jason W. Skudlarek 2015-10-13
9139576 Aminomethyl biaryl benzotriazole derivatives Douglas C. Beshore, Robert M. Garbaccio, Adam W. Johnson, Jason W. Skudlarek 2015-09-22
9029364 2,5-disubstituted thiomorpholine orexin receptor antagonists Christina Ng Di Marco 2015-05-12